• About Us  
    • Our Mission
    • Company Profile
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Clinical Advisory Board
  • ProTcell platform
  • Pipeline
  • FAQ
  • News & Resources  
    • Press releases
    • Smart Stories
  • Partnering
  • Contact

Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

Smart Immune is selected for the first cohort of the French Tech Health20 program

March 24, 2023

1st leukemia patient dosed with SMART101 at MSK

January 23, 2023

Smart Immune appoints world-class Clinical Advisory Board

November 21, 2022

Smart Immune and Greater Paris University Hospitals (AP-HP) begin groundbreaking Phase I/II trial with ProTcellTM, a thymus-empowered T-cell therapy platform, in adults with blood cancers

October 13, 2022

Smart Immune Bolsters Management Team with Medical and Technical Appointments

September 13, 2022

Smart Immune appoints world-leading experts to its Scientific Advisory Board 

July 28, 2022
←
Previous
Next
→
© 2021 Smart Immune SAS
Legal Notice
